NCT07159802 Papillary Reconstruction Using Three Different Modalities
| NCT ID | NCT07159802 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mansoura University |
| Condition | Papillary Reconstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 24 participants |
| Start Date | 2025-02-25 |
| Primary Completion | 2026-04-25 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 24 participants in total. It began in 2025-02-25 with a primary completion date of 2026-04-25.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
papillary reconstruction will be done by three techniques : injection of hyaluronic acid in the base of the papilla and booster doses can be required , injection of ALB-PRF which resorbs slowly and so longer effect the last technique is minimal invasive surgery which is a modification of beagle's technique
Eligibility Criteria
Inclusion Criteria: * 1\. Age: 20 to 50 years. 2. Class 1 and 2 inter dental papilla loss according to Nordland \& Tarnow classification (17). 3\. Adequate attached gingiva (minimum 3 mm). 4. Stage 1or 2 periodontitis (18). Exclusion Criteria: * 1\. Smokers. 2. Chronic systemic diseases. 3. Drug usage. 4. High frenum attachment. 5. Diastema. 6. Pregnancy and lactation. 7. Stage 3 \& 4 periodontitis (18). 8. Noncompliance with oral hygiene measures.
Contact & Investigator
Tasneem E Abdallah, BDS
PRINCIPAL INVESTIGATOR
Mansoura University
Frequently Asked Questions
Who can join the NCT07159802 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 50 Years, studying Papillary Reconstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07159802 currently recruiting?
Yes, NCT07159802 is actively recruiting participants. Contact the research team at tasneemehabgamal@mans.edu.eg for enrollment information.
Where is the NCT07159802 trial being conducted?
This trial is being conducted at Al Mansurah, Egypt.
Who is sponsoring the NCT07159802 clinical trial?
NCT07159802 is sponsored by Mansoura University. The principal investigator is Tasneem E Abdallah, BDS at Mansoura University. The trial plans to enroll 24 participants.